These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10384205)

  • 1. Reversal of refractory hypotension with single-dose methylene blue after coronary artery bypass surgery.
    Yiu P; Robin J; Pattison CW
    J Thorac Cardiovasc Surg; 1999 Jul; 118(1):195-6. PubMed ID: 10384205
    [No Abstract]   [Full Text] [Related]  

  • 2. Methylene blue for refractory hypotension: a case report.
    Weissgerber AJ
    AANA J; 2008 Aug; 76(4):271-4. PubMed ID: 18777811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylene blue during cardiopulmonary bypass to treat refractory hypotension in septic endocarditis.
    Grayling M; Deakin CD
    J Thorac Cardiovasc Surg; 2003 Feb; 125(2):426-7. PubMed ID: 12579121
    [No Abstract]   [Full Text] [Related]  

  • 4. Methylene blue for lithium-induced refractory hypotension in off-pump coronary artery bypass graft: report of two cases.
    Sparicio D; Landoni G; Pappalardo F; Crivellari M; Cerchierini E; Marino G; Zangrillo A
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):592-3. PubMed ID: 14762380
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of methylene blue for catecholamine-refractory vasoplegia from protamine and aprotinin.
    Del Duca D; Sheth SS; Clarke AE; Lachapelle KJ; Ergina PL
    Ann Thorac Surg; 2009 Feb; 87(2):640-2. PubMed ID: 19161806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasoplegic syndrome--the role of methylene blue.
    Shanmugam G
    Eur J Cardiothorac Surg; 2005 Nov; 28(5):705-10. PubMed ID: 16143539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The response to methylene blue in patients with severe hypotension during liver transplantation.
    Cheng SS; Berman GW; Merritt GR; Hendrickse A; Fiegel MJ; Teitelbaum I; Campsen J; Wachs M; Zimmerman M; Mandell MS
    J Clin Anesth; 2012 Jun; 24(4):324-8. PubMed ID: 22608589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hemodynamic effects of methylene blue when administered at the onset of cardiopulmonary bypass.
    Maslow AD; Stearns G; Butala P; Schwartz CS; Gough J; Singh AK
    Anesth Analg; 2006 Jul; 103(1):2-8, table of contents. PubMed ID: 16790616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylene blue: the drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass?
    Leyh RG; Kofidis T; Strüber M; Fischer S; Knobloch K; Wachsmann B; Hagl C; Simon AR; Haverich A
    J Thorac Cardiovasc Surg; 2003 Jun; 125(6):1426-31. PubMed ID: 12830064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylene blue, midodrine, and pseudoephedrine: a review of alternative agents for refractory hypotension in the intensive care unit.
    Van Berkel MA; Fuller LA; Alexandrov AW; Jones GM
    Crit Care Nurs Q; 2015; 38(4):345-58. PubMed ID: 26335214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylene blue revisited: management of hypotension in a pediatric patient with bacterial endocarditis.
    Taylor K; Holtby H
    J Thorac Cardiovasc Surg; 2005 Aug; 130(2):566. PubMed ID: 16077431
    [No Abstract]   [Full Text] [Related]  

  • 12. Preoperative methylene blue administration in patients at high risk for vasoplegic syndrome during cardiac surgery.
    Ozal E; Kuralay E; Yildirim V; Kilic S; Bolcal C; Kücükarslan N; Günay C; Demirkilic U; Tatar H
    Ann Thorac Surg; 2005 May; 79(5):1615-9. PubMed ID: 15854942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-converting enzyme inhibitors predispose to hypotension refractory to norepinephrine but responsive to methylene blue.
    Sparicio D; Landoni G; Zangrillo A
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):608. PubMed ID: 14762391
    [No Abstract]   [Full Text] [Related]  

  • 14. Administration of methylene blue in human septic shock: renaissance of an old drug?
    Evgenov OV; Bjertnaes LJ
    Crit Care Med; 2003 May; 31(5):1601-2; author reply 1602. PubMed ID: 12771654
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of intravenous methylene blue for the treatment of refractory hypotension after cardiopulmonary bypass.
    Pagni S; Austin EH
    J Thorac Cardiovasc Surg; 2000 Jun; 119(6):1297-8. PubMed ID: 10838557
    [No Abstract]   [Full Text] [Related]  

  • 16. Methylene blue in the treatment of vasoplegia following severe burns.
    Jaskille AD; Jeng JC; Jordan MH
    J Burn Care Res; 2008; 29(2):408-10. PubMed ID: 18354304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative hemodynamic effects of vasopressin and norepinephrine after milrinone-induced hypotension in off-pump coronary artery bypass surgical patients.
    Jeon Y; Ryu JH; Lim YJ; Kim CS; Bahk JH; Yoon SZ; Choi JY
    Eur J Cardiothorac Surg; 2006 Jun; 29(6):952-6. PubMed ID: 16675238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylene blue: the Trojan horse.
    Weiner MM; Fischer GW
    J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):e13-4. PubMed ID: 24630473
    [No Abstract]   [Full Text] [Related]  

  • 19. Vasoplegic syndrome during liver transplantation.
    Cao Z; Gao Y; Tao G
    Anesth Analg; 2009 Jun; 108(6):1941-3. PubMed ID: 19448226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylene blue administration in severe systemic inflammatory response syndrome (SIRS) after thoracic surgery.
    Friedrich M; Bräuer A; Tirilomis T; Lotfi S; Mielck F; Busch T
    Ann Thorac Cardiovasc Surg; 2002 Oct; 8(5):306-10. PubMed ID: 12472415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.